Search

Catalent helps its partners accelerate more than 1,000 programs and launch over 150 new products every year

Implementing Industry 4.0 concepts for the best manufacturing outcomes.

It’s been a busy start to the year for biopharma, with a plethora of new announcements.

Pharma experts convened at the Pharmaceutical Industry Network Group’s annual conference to discuss the UK’s position in pharmaceutical innovation.

While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

Can newly discovered antibodies help us do away with annual flu vaccinations?

After other defendants in the case settle, Teva is left to face the music in New York alone.

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

A technique comparable to the alternative medicinal practice of “cupping” has shown potential in improving delivery of nucleic acid medicines.